fluconazole has been researched along with Aging in 4 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"The pharmacokinetic properties of fluconazole were studied in more than 100 pediatric patients, including 12 premature neonates." | 1.29 | Pharmacokinetics of fluconazole in pediatric patients. ( Brammer, KW; Coates, PE, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wils, J | 1 |
Djerada, Z | 1 |
Roca, F | 1 |
Duflot, T | 1 |
Iacob, M | 1 |
Remy-Jouet, I | 1 |
Joannides, R | 1 |
Bellien, J | 1 |
Fucic, A | 1 |
Markovic, D | 1 |
Herceg, Z | 1 |
Gamulin, M | 1 |
Katic, J | 1 |
Stojkovic, R | 1 |
Ferencic, Z | 1 |
Mildner, B | 1 |
Jazbec, AM | 1 |
Dobranic, T | 1 |
Brammer, KW | 1 |
Coates, PE | 1 |
Dudley, MN | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pharmacokinetics of a Fluconazole Loading Dose in Infants and Toddlers[NCT00797420] | Phase 1 | 13 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for fluconazole and Aging
Article | Year |
---|---|
Clinical pharmacology of fluconazole.
Topics: Absorption; Aging; Bone Marrow Transplantation; Fluconazole; Humans; Kidney Diseases; Molecular Stru | 1990 |
3 other studies available for fluconazole and Aging
Article | Year |
---|---|
Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging.
Topics: Adult; Age Factors; Aged; Aging; Cytochrome P-450 Enzyme Inhibitors; Eicosanoids; Endothelium, Vascu | 2018 |
Developmental and transplacental genotoxicology: fluconazole.
Topics: Aging; Animals; Female; Fluconazole; Maternal-Fetal Exchange; Mice; Mice, Inbred BALB C; Micronucleu | 2008 |
Pharmacokinetics of fluconazole in pediatric patients.
Topics: Administration, Oral; Adolescent; Aging; Body Weight; Child; Child, Preschool; Fluconazole; Humans; | 1994 |